{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-080497","form_type":"8-K","ticker":"ATOS","cik":"0001488039","company_name":"ATOSSA THERAPEUTICS, INC.","filed_at":"2024-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.220478+00:00","generated_at":"2026-05-31T23:45:21.782853+00:00","sec_items":["5.02","5.03","5.07","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Atossa appoints Heather Rees as CFO, increases authorized shares to 360M","bullets":["Heather Rees appointed CFO effective June 27, 2024; salary set at $439,700 with 40% bonus target.","Rees granted 577,700 stock options vesting quarterly over two years under the 2020 Plan.","Stockholders approved increase in authorized common shares from 175M to 350M (total authorized to 360M).","Amendment and restatement of 2020 Stock Incentive Plan approved, adding 12M shares."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-080497","json":"https://secwatch.observer/filing/0000950170-24-080497.json","markdown":"https://secwatch.observer/filing/0000950170-24-080497.md","text":"https://secwatch.observer/filing/0000950170-24-080497.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1488039/000095017024080497/0000950170-24-080497-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1488039/000095017024080497/atos-20240627.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:45:21.782853+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c4ec0377cf","claim":"Heather Rees was appointed as Chief Financial Officer at ATOSSA THERAPEUTICS, INC..","evidence_excerpt":"On June 27, 2024, the Board of Directors (the “Board”) of the Company appointed Heather Rees, previously the Company’s Senior Vice President, Finance and Accounting, to serve as Chief Financial Officer and to continue serving as principal financial and accounting officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017024080497/0000950170-24-080497-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}